MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis

Kentaro Yamamoto, Akiyuki Uzawa, Genta Narazaki, Yoshikazu Nezu, Mami Yamazaki, Hirofumi Kondo, Kozo Yoneda, Masaya Shimada, Chigusa Yoshimura, Yoko Nakano, Manato Yasuda, Hiroyuki Akamine, Yosuke Onishi, Hideo Handa, Etsuko Ogaya, Tomonori Kunikata, Ryutaro Nakashima, Hidenori Takahashi, Tomohiro Nishizawa, Satoshi Kuwabara, Kiyosumi Takaishi

Open source

DOI: 10.1016/j.neurot.2026.e01090
Published: 2026-10
Container: Neurotherapeutics
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2026.e01090,
  title = {MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis},
  author = {Kentaro Yamamoto and Akiyuki Uzawa and Genta Narazaki and Yoshikazu Nezu and Mami Yamazaki and Hirofumi Kondo and Kozo Yoneda and Masaya Shimada and Chigusa Yoshimura and Yoko Nakano and Manato Yasuda and Hiroyuki Akamine and Yosuke Onishi and Hideo Handa and Etsuko Ogaya and Tomonori Kunikata and Ryutaro Nakashima and Hidenori Takahashi and Tomohiro Nishizawa and Satoshi Kuwabara and Kiyosumi Takaishi},
  year = {2026},
  journal = {Neurotherapeutics},
  doi = {10.1016/j.neurot.2026.e01090},
  url = {https://doi.org/10.1016/j.neurot.2026.e01090}
}

RIS

TY  - JOUR
TI  - MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis
AU  - Kentaro Yamamoto
AU  - Akiyuki Uzawa
AU  - Genta Narazaki
AU  - Yoshikazu Nezu
AU  - Mami Yamazaki
AU  - Hirofumi Kondo
AU  - Kozo Yoneda
AU  - Masaya Shimada
AU  - Chigusa Yoshimura
AU  - Yoko Nakano
AU  - Manato Yasuda
AU  - Hiroyuki Akamine
AU  - Yosuke Onishi
AU  - Hideo Handa
AU  - Etsuko Ogaya
AU  - Tomonori Kunikata
AU  - Ryutaro Nakashima
AU  - Hidenori Takahashi
AU  - Tomohiro Nishizawa
AU  - Satoshi Kuwabara
AU  - Kiyosumi Takaishi
PY  - 2026
JO  - Neurotherapeutics
DO  - 10.1016/j.neurot.2026.e01090
UR  - https://doi.org/10.1016/j.neurot.2026.e01090
ER  -

APA

Yamamoto, K., Uzawa, A., Narazaki, G., Nezu, Y., Yamazaki, M., Kondo, H., Yoneda, K., Shimada, M., Yoshimura, C., Nakano, Y., Yasuda, M., Akamine, H., Onishi, Y., Handa, H., Ogaya, E., Kunikata, T., Nakashima, R., Takahashi, H., Nishizawa, T., Kuwabara, S., & Takaishi, K. (2026). MuSK agonistic antibody has therapeutic potential for MuSK antibody-positive myasthenia gravis. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e01090

Source records

crossref · retrieved 2026-11-10T15:53:14.503Z